Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Farrell

Showing results (21-30 of 522) with videos related to

Pageof 53
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2015
Heroin-assisted treatment: has a controversial treatment come of age?†Michael Farrell, Wayne Hall
The Lancet. Public Health|April 23, 2018
Prisoners and risk of injury after releaseWayne Hall, Michael Farrell
Addiction (Abingdon, England)|February 9, 2012
Opioid maintenance in European prisons: is the treatment gap closing?Dagmar Hedrich, Michael Farrell
Addiction (Abingdon, England)|October 28, 2015
Which medications are suitable for agonist drug maintenance?Shane Darke, Michael Farrell
Addiction (Abingdon, England)|February 11, 2016
Commentary on Binswanger et al. (2016): Multiple opportunities exist to improve the health and wellbeing of people released from prisonsSarah Larney, Michael Farrell
Addiction (Abingdon, England)|August 12, 2021
What can we learn from the history of research on psychedelic drugs in the addictions?Wayne Hall, Michael Farrell
Clinical Rheumatology|April 27, 2010
Cerebral tuberculoma in a patient receiving anti-TNF alpha (adalimumab) treatmentKaren Lynch, Michael Farrell
The Practitioner|June 15, 2007
Harm reduction the key to managing problem drug usersWilliam Flannery, Michael Farrell
Infection Control and Hospital Epidemiology|April 9, 2015
A practical approach to avoiding iatrogenic Creutzfeldt-Jakob disease (CJD) from invasive instrumentsPaul Brown, Michael Farrell
Addiction (Abingdon, England)|January 23, 2020
Commentary on Ho et al. (2020): Managing people with HIV and drug problems is complex and multi-facetedMichael Farrell, Roy Robertson
Pageof 53

Showing results (21-30 of 522) with videos related to

Sort By:
Pageof 53
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2015
Heroin-assisted treatment: has a controversial treatment come of age?†Michael Farrell, Wayne Hall
The Lancet. Public Health|April 23, 2018
Prisoners and risk of injury after releaseWayne Hall, Michael Farrell
Addiction (Abingdon, England)|February 9, 2012
Opioid maintenance in European prisons: is the treatment gap closing?Dagmar Hedrich, Michael Farrell
Addiction (Abingdon, England)|October 28, 2015
Which medications are suitable for agonist drug maintenance?Shane Darke, Michael Farrell
Addiction (Abingdon, England)|February 11, 2016
Commentary on Binswanger et al. (2016): Multiple opportunities exist to improve the health and wellbeing of people released from prisonsSarah Larney, Michael Farrell
Addiction (Abingdon, England)|August 12, 2021
What can we learn from the history of research on psychedelic drugs in the addictions?Wayne Hall, Michael Farrell
Clinical Rheumatology|April 27, 2010
Cerebral tuberculoma in a patient receiving anti-TNF alpha (adalimumab) treatmentKaren Lynch, Michael Farrell
The Practitioner|June 15, 2007
Harm reduction the key to managing problem drug usersWilliam Flannery, Michael Farrell
Infection Control and Hospital Epidemiology|April 9, 2015
A practical approach to avoiding iatrogenic Creutzfeldt-Jakob disease (CJD) from invasive instrumentsPaul Brown, Michael Farrell
Addiction (Abingdon, England)|January 23, 2020
Commentary on Ho et al. (2020): Managing people with HIV and drug problems is complex and multi-facetedMichael Farrell, Roy Robertson
Pageof 53